Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901669438> ?p ?o ?g. }
- W2901669438 endingPage "7548" @default.
- W2901669438 startingPage "7533" @default.
- W2901669438 abstract "Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer Zeting Yuan,1,* Yuxia Yuan,1,* Lin Han,2 Yanyan Qiu,1 Xiaqin Huang,3 Feng Gao,3 Guohua Fan,1 Yixi Zhang,1 Xueyao Tang,1 Xue He,1 Ke Xu,1 Peihao Yin1,4,5 1Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People’s Republic of China; 2Experimental Research Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People’s Republic of China; 3Department of Pharmaceutics, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, People’s Republic of China; 4Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People’s Republic of China; 5Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Anhui 230022, People’s Republic of China *These authors contributed equally to this work Background: Multidrug resistance (MDR) is the major reason for the failure of chemotherapy in colon cancer. Bufalin (BU) is one of the most effective antitumor active constituents in Chansu. Our previous study found that BU can effectively reverse P-glycoprotein (P-gp)-mediated MDR in colon cancer. However, the clinical application of BU is limited due to its low solubility in water and high toxicity. In the present study, a multifunctional delivery system based on vitamin-E-succinate grafted chitosan oligosaccharide (VES-CSO) and cyclic (arginine-glycine-aspartic acid peptide) (RGD)-modified d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) was prepared by emulsion solvent evaporation method for targeted delivery of BU to improve the efficacy of drug-resistant colon cancer therapy.Methods: The cytotoxicity of BU-loaded micelles against drug-resistant colon cancer LoVo/ADR and HCT116/LOHP cells was measured by CCK-8 assay. The cellular uptake, Rho123 accumulation, and cell apoptosis were determined by flow cytometry. The expression of apoptosis-related protein and P-gp was measured by Western blot assay. The antitumor activity of BU-loaded micelles was evaluated in LoVo/ADR-bearing nude mice.Results: BU-loaded VES-CSO/TPGS-RGD mixed micelles (BU@VeC/T-RGD MM) were 140.3 nm in diameter with zeta potential of 8.66 mV. The BU@VeC/T-RGD MM exhibited good stability, sustained-release pattern, higher intracellular uptake, and greater cytotoxicity in LoVo/ADR cells. Furthermore, the mechanisms of the BU@VeC/T-RGD MM to overcome MDR might be due to enhanced apoptosis rate and P-gp efflux inhibition. Subsequently, in vivo studies confirmed an enhanced therapeutic efficiency and reduced side effects associated with BU@VeC/T-RGD MM compared with free BU, owing to the enhanced permeation and retention effect, improved pharmacokinetic behavior, and tumor targeting, which lead to MDR-inhibiting effect in LoVo/ADR-bearing nude mice.Conclusion: Our results demonstrated that VeC/T-RGD MM could be developed as a potential delivery system for BU to improve its antitumor activity against drug-resistant colon cancer. Keywords: bBufalin, colon cancer, multidrug resistance, mixed micelle, tumor targeting, P-gp" @default.
- W2901669438 created "2018-11-29" @default.
- W2901669438 creator A5023015199 @default.
- W2901669438 creator A5024085884 @default.
- W2901669438 creator A5029954684 @default.
- W2901669438 creator A5038061609 @default.
- W2901669438 creator A5048169926 @default.
- W2901669438 creator A5054614913 @default.
- W2901669438 creator A5061030350 @default.
- W2901669438 creator A5061893226 @default.
- W2901669438 creator A5066894792 @default.
- W2901669438 creator A5073508266 @default.
- W2901669438 creator A5091118782 @default.
- W2901669438 creator A5091146388 @default.
- W2901669438 date "2018-11-01" @default.
- W2901669438 modified "2023-10-03" @default.
- W2901669438 title "Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer" @default.
- W2901669438 cites W1677199798 @default.
- W2901669438 cites W1848317053 @default.
- W2901669438 cites W1979235615 @default.
- W2901669438 cites W1981915038 @default.
- W2901669438 cites W1986883825 @default.
- W2901669438 cites W1990118372 @default.
- W2901669438 cites W2002813710 @default.
- W2901669438 cites W2016046859 @default.
- W2901669438 cites W2023677664 @default.
- W2901669438 cites W2025665604 @default.
- W2901669438 cites W2032167680 @default.
- W2901669438 cites W2032222317 @default.
- W2901669438 cites W2051044253 @default.
- W2901669438 cites W2061215349 @default.
- W2901669438 cites W2067946566 @default.
- W2901669438 cites W2088112191 @default.
- W2901669438 cites W2088415033 @default.
- W2901669438 cites W2097632835 @default.
- W2901669438 cites W2097997523 @default.
- W2901669438 cites W2099797949 @default.
- W2901669438 cites W2110922654 @default.
- W2901669438 cites W2168709731 @default.
- W2901669438 cites W2190219040 @default.
- W2901669438 cites W2233759731 @default.
- W2901669438 cites W2381727044 @default.
- W2901669438 cites W2513524633 @default.
- W2901669438 cites W2540104635 @default.
- W2901669438 cites W2553482387 @default.
- W2901669438 cites W2580010201 @default.
- W2901669438 cites W2588451587 @default.
- W2901669438 cites W2611827085 @default.
- W2901669438 cites W2619084621 @default.
- W2901669438 cites W2622124630 @default.
- W2901669438 cites W2724321477 @default.
- W2901669438 cites W2736086618 @default.
- W2901669438 cites W2736186352 @default.
- W2901669438 cites W2781525129 @default.
- W2901669438 cites W2791277907 @default.
- W2901669438 cites W2791437922 @default.
- W2901669438 cites W2793096195 @default.
- W2901669438 doi "https://doi.org/10.2147/ijn.s170692" @default.
- W2901669438 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6241863" @default.
- W2901669438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30532537" @default.
- W2901669438 hasPublicationYear "2018" @default.
- W2901669438 type Work @default.
- W2901669438 sameAs 2901669438 @default.
- W2901669438 citedByCount "25" @default.
- W2901669438 countsByYear W29016694382020 @default.
- W2901669438 countsByYear W29016694382021 @default.
- W2901669438 countsByYear W29016694382022 @default.
- W2901669438 countsByYear W29016694382023 @default.
- W2901669438 crossrefType "journal-article" @default.
- W2901669438 hasAuthorship W2901669438A5023015199 @default.
- W2901669438 hasAuthorship W2901669438A5024085884 @default.
- W2901669438 hasAuthorship W2901669438A5029954684 @default.
- W2901669438 hasAuthorship W2901669438A5038061609 @default.
- W2901669438 hasAuthorship W2901669438A5048169926 @default.
- W2901669438 hasAuthorship W2901669438A5054614913 @default.
- W2901669438 hasAuthorship W2901669438A5061030350 @default.
- W2901669438 hasAuthorship W2901669438A5061893226 @default.
- W2901669438 hasAuthorship W2901669438A5066894792 @default.
- W2901669438 hasAuthorship W2901669438A5073508266 @default.
- W2901669438 hasAuthorship W2901669438A5091118782 @default.
- W2901669438 hasAuthorship W2901669438A5091146388 @default.
- W2901669438 hasBestOaLocation W29016694381 @default.
- W2901669438 hasConcept C121608353 @default.
- W2901669438 hasConcept C126322002 @default.
- W2901669438 hasConcept C133936738 @default.
- W2901669438 hasConcept C142724271 @default.
- W2901669438 hasConcept C185592680 @default.
- W2901669438 hasConcept C188947578 @default.
- W2901669438 hasConcept C204787440 @default.
- W2901669438 hasConcept C501593827 @default.
- W2901669438 hasConcept C55493867 @default.
- W2901669438 hasConcept C556039675 @default.
- W2901669438 hasConcept C71924100 @default.
- W2901669438 hasConcept C98274493 @default.
- W2901669438 hasConceptScore W2901669438C121608353 @default.
- W2901669438 hasConceptScore W2901669438C126322002 @default.
- W2901669438 hasConceptScore W2901669438C133936738 @default.
- W2901669438 hasConceptScore W2901669438C142724271 @default.